MindWalk Holdings (HYFT) Total Current Liabilities (2020 - 2026)
MindWalk Holdings (HYFT) reported Total Current Liabilities of $3.6 million for Q1 2026, down 42.4% year-over-year from $6.3 million in Q1 2025, and down 3.14% quarter-over-quarter from $3.7 million in Q4 2025.
MindWalk Holdings (HYFT) Total Current Liabilities (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Total Current Liabilities data on file, last reported at $3.6 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $3.6 million, down 42.4% year-over-year; the trailing twelve-month figure through Jan 2026 was $3.6 million (down 42.4% YoY), and the FY2025 annual result was $6.5 million, up 7.98% from the prior year.
- Total Current Liabilities fell to $3.6 million in Q1 2026 per HYFT's latest filing, from $3.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $12.1 million in Q3 2025 and troughed at $3.6 million in Q1 2026.
- A 5-year average of $6.1 million and a median of $5.6 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 69.65% in 2024, then plunged 58.82% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $5.5 million in 2022, then climbed by 1.01% to $5.6 million in 2023, then soared by 63.54% to $9.1 million in 2024, then sank by 58.82% to $3.7 million in 2025, then retreated by 3.14% to $3.6 million in 2026.
- Business Quant data shows HYFT's Total Current Liabilities at $3.6 million in Q1 2026, $3.7 million in Q4 2025, and $12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 72.86 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 3.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 3.62 Mn |
| Oct 31, 2025 | 3.74 Mn |
| Jul 31, 2025 | 12.15 Mn |
| Apr 30, 2025 | 6.33 Mn |
| Jan 31, 2025 | 6.29 Mn |
| Oct 31, 2024 | 9.09 Mn |
| Jul 31, 2024 | 8.16 Mn |
| Apr 30, 2024 | 5.99 Mn |
| Jan 31, 2024 | 6.72 Mn |
| Oct 31, 2023 | 5.56 Mn |
| Jul 31, 2023 | 4.81 Mn |
| Apr 30, 2023 | 4.38 Mn |
| Jan 31, 2023 | 4.93 Mn |
| Oct 31, 2022 | 5.50 Mn |
| Jul 31, 2022 | 4.16 Mn |
| Apr 30, 2022 | 7.34 Mn |
| Jan 31, 2022 | 5.64 Mn |
| Oct 31, 2021 | 5.99 Mn |
| Jul 31, 2021 | 5.39 Mn |
| Apr 30, 2021 | 4.82 Mn |